Biosite Incorporated Reports New Option Grants Under NASDAQ Marketplace Rule 4350
May 02 2007 - 9:01PM
PR Newswire (US)
SAN DIEGO, May 2 /PRNewswire-FirstCall/ -- Biosite(R) Incorporated
(NASDAQ:BSTE), today announced that, in accordance with NASDAQ
Marketplace Rule 4350, 18 non-officer employees were granted
inducement stock options covering an aggregate of 17,200 shares of
common stock. These options were granted pursuant to NASDAQ
Marketplace Rule 4350 (i)(1)(A)(iv) with the following terms: each
option has been classified as a non-qualified stock option, has an
exercise price equal to the fair market value on the grant date,
has a ten-year term, and vests in 16 equal quarterly installments
over four years (on each quarterly anniversary of the applicable
vesting commencement date). About Biosite Incorporated Biosite
Incorporated is a leading bio-medical company commercializing
proteomics discoveries for the advancement of medical diagnosis.
The Company's products contribute to improvements in medical care
by aiding physicians in the diagnosis of critical diseases and
health conditions. The Biosite(R) Triage(R) rapid diagnostic tests
are used in more than 70 percent of U.S. hospitals and in more than
60 international markets. Information on Biosite can be found at
http://www.biosite.com/. Biosite(R) Triage(R) and New Dimensions in
Diagnosis(R) are registered trademarks of Biosite Incorporated. The
Company's logo is a trademark of Biosite Incorporated. DATASOURCE:
Biosite Incorporated CONTACT: Nadine Padilla, Vice President,
Corporate & Investor Relations, of Biosite Incorporated,
+1-858-805-2820, Web site: http://www.biosite.com/ Company News
On-Call: http://www.prnewswire.com/comp/116737.html
Copyright
Biosite (NASDAQ:BSTE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Biosite (NASDAQ:BSTE)
Historical Stock Chart
From Jul 2023 to Jul 2024